Articles from Inspection Monitor (November 1, 1998)

Title	Author	Type	Words
All drugs, few biologics to get scheduled audits : CBER resisting due to ORA turf takeover.		Brief Article	601
Biosera license revoked after multiple violations.			1333
Boehringer EIR hints at next audit's targets.		Brief Article	385
Chemical firm requests audit for drug transition.		Brief Article	395
INSPECTION LOG.		Brief Article	559
Japanese chemical plant faulted on API validation.		Brief Article	820
Minntech follow-up confirms corrections.		Brief Article	240
Mismatched mailers misdirect HIV test kits.		Brief Article	550
Peritonitis reports spur changes at Fresenius.			1069
Poor failure response may pose risk to 510(k)s.		Brief Article	728
Terumo cited for flaws in validation and testing.		Brief Article	594